David Canes to Neoplasm Invasiveness
This is a "connection" page, showing publications David Canes has written about Neoplasm Invasiveness.
Connection Strength
0.068
-
Browne BM, Stensland KD, Patel CK, Sullivan T, Burks EJ, Canes D, Raman JD, Warrick J, Reiger-Christ KM. MicroRNA Expression Profiles in Upper Tract Urothelial Carcinoma Differentiate Tumor Grade, Stage, and Survival: Implications for Clinical Decision-Making. Urology. 2019 01; 123:93-100.
Score: 0.035
-
Gould JJ, Kenney PA, Rieger-Christ KM, Silva Neto B, Wszolek MF, LaVoie A, Holway AH, Spurrier B, Austin J, Cammarata BK, Canes D, Libertino JA, Summerhayes IC. Identification of tumor and invasion suppressor gene modulators in bladder cancer by different classes of histone deacetylase inhibitors using reverse phase protein arrays. J Urol. 2010 Jun; 183(6):2395-402.
Score: 0.019
-
Chiang GJ, Billmeyer BR, Canes D, Stoffel J, Moinzadeh A, Austin CA, Kosakowski M, Rieger-Christ KM, Libertino JA, Summerhayes IC. The src-family kinase inhibitor PP2 suppresses the in vitro invasive phenotype of bladder carcinoma cells via modulation of Akt. BJU Int. 2005 Aug; 96(3):416-22.
Score: 0.014